» Articles » PMID: 16822091

Review of Treatments That Can Ameliorate Nonadherence in Patients with Schizophrenia

Overview
Specialty Psychiatry
Date 2006 Jul 11
PMID 16822091
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

Nonadherence to medication is one of the major problems in treating patients with schizophrenia. Clinicians can use a variety of assessment strategies to identify patients who are nonadherent, although none of these is completely reliable. Interventions to improve adherence include psychosocial strategies, second-generation oral antipsychotics, and long-acting injectable antipsychotics. Because of the potential for reduced relapse and rehospitalization rates and the availability of second-generation antipsychotics in injectable form, a case is made for using long-acting injectable second-generation antipsychotics, when appropriate, to treat patients with schizophrenia.

Citing Articles

Cerebral, Psychosocial, Family Functioning and Disability of Persons with Schizophrenia.

Valencia M, Medina R, Calixto E, Rodriguez N Neuropsychiatr Dis Treat. 2022; 18:2069-2082.

PMID: 36133029 PMC: 9484561. DOI: 10.2147/NDT.S370449.


Switch from Olanzapine Long-Acting Injectable to its Oral Equivalent during COVID-19 Pandemic: a Real World Observational Study.

Miron A, Teodorescu A, Ifteni P, Irimie C, Dima L, Petric P Psychiatr Q. 2022; 93(2):627-635.

PMID: 35235126 PMC: 8888267. DOI: 10.1007/s11126-021-09924-9.


Digitally Enabled, Patient-Centric Clinical Trials: Shifting the Drug Development Paradigm.

Dockendorf M, Hansen B, Bateman K, Moyer M, Shah J, Shipley L Clin Transl Sci. 2020; 14(2):445-459.

PMID: 33048475 PMC: 7993267. DOI: 10.1111/cts.12910.


Hospitalization and Some Sociodemographic Characteristics of Patients Registered with a Community Mental Health Center.

Ersan E Community Ment Health J. 2019; 56(3):498-505.

PMID: 31734764 DOI: 10.1007/s10597-019-00506-5.


Symptomatic stability with aripiprazole once-monthly: efficacy analyses from acute and long-term studies.

Madera J, Such P, Zhao C, Baker R Neuropsychiatr Dis Treat. 2019; 15:1593-1604.

PMID: 31354275 PMC: 6590622. DOI: 10.2147/NDT.S198786.